Nursedive logo NurseDive
NurseDive

Nursing practice questions with comprehensive rationales

Start Free

NurseDive Free Nursing Practice Question

A nurse is assessing a client who has Lewy body dementia. The nurse should recognize that which of the following is responsible for changes in thinking, communication, movement, and emotional processing in Lewy body dementia?

A. Tau protein

Tau protein: Tau protein is primarily associated with Alzheimer's disease and other tauopathies, not Lewy body dementia.

B. Neurofibrillary tangles

Neurofibrillary tangles: Neurofibrillary tangles are aggregates of hyperphosphorylated tau protein found in Alzheimer's disease, not typically in Lewy body dementia.

C. Alpha-synuclein protein

Alpha-synuclein protein: Lewy bodies, which are abnormal aggregates of alpha-synuclein protein, are a hallmark pathology of Lewy body dementia. These protein aggregates disrupt neuronal function and are responsible for the cognitive, motor, and emotional symptoms seen in Lewy body dementia.

D. Beta-amyloid protein

Beta-amyloid protein: Beta-amyloid protein is primarily associated with Alzheimer's disease, not Lewy body dementia. It forms plaques in the brain, which contribute to neurodegeneration and cognitive decline in Alzheimer's disease.

This question is an excerpt from Nurse Dive's nursing test bank - Ati Med Surg Proctored Exam 1 2024. Take the full exam now


Full Explanation

A. Tau protein: Tau protein is primarily associated with Alzheimer's disease and other tauopathies, not Lewy body dementia.

B. Neurofibrillary tangles: Neurofibrillary tangles are aggregates of hyperphosphorylated tau protein found in Alzheimer's disease, not typically in Lewy body dementia.

C. Alpha-synuclein protein: Lewy bodies, which are abnormal aggregates of alpha-synuclein protein, are a hallmark pathology of Lewy body dementia. These protein aggregates disrupt neuronal function and are responsible for the cognitive, motor, and emotional symptoms seen in Lewy body dementia.

D. Beta-amyloid protein: Beta-amyloid protein is primarily associated with Alzheimer's disease, not Lewy body dementia. It forms plaques in the brain, which contribute to neurodegeneration and cognitive decline in Alzheimer's disease.


Similar Questions

QUESTION

A nurse is collecting data from an admission history for a client who reports being tackled while playing football and is now seeing bright flashes of light and dark floating spots. Which of the following conditions should the nurse expect the client to be experiencing?

A. Open-angle glaucoma

Open-angle glaucoma: Open-angle glaucoma typically presents with increased intraocular pressure and gradual loss of peripheral vision, not with bright flashes of light and dark floating spots.

B. Macular degeneration

Macular degeneration: Macular degeneration is characterized by central vision loss, not by bright flashes of light and dark floating spots.

C. Meniere’s disease

Meniere’s disease: Meniere’s disease is a disorder of the inner ear characterized by episodes of vertigo, hearing loss, and tinnitus. It does not typically cause bright flashes of light and dark floating spots in the visual field.

D. Retinal detachment

Retinal detachment: Trauma, such as being tackled while playing football, can lead to retinal detachment, which can manifest with symptoms such as bright flashes of light (photopsia) and dark floating spots (floaters) in the affected eye. This condition is considered a medical emergency and requires prompt evaluation and treatment to prevent permanent vision loss.

Full Explanation

A. Open-angle glaucoma: Open-angle glaucoma typically presents with increased intraocular pressure and gradual loss of peripheral vision, not with bright flashes of light and dark floating spots.

B. Macular degeneration: Macular degeneration is characterized by central vision loss, not by bright flashes of light and dark floating spots.

C. Meniere’s disease: Meniere’s disease is a disorder of the inner ear characterized by episodes of vertigo, hearing loss, and tinnitus. It does not typically cause bright flashes of light and dark floating spots in the visual field.

D. Retinal detachment: Trauma, such as being tackled while playing football, can lead to retinal detachment, which can manifest with symptoms such as bright flashes of light (photopsia) and dark floating spots (floaters) in the affected eye. This condition is considered a medical emergency and requires prompt evaluation and treatment to prevent permanent vision loss.

QUESTION

A nurse is teaching a group of clients about risk factors for developing atrial flutter. Which of the following clients should the nurse understand is at highest risk for developing atrial flutter?

A. The client who is out of work and has been experiencing increased stress.

Stress can contribute to the development of atrial flutter, but it is not the highest risk factor compared to other options.

B. The client who is recovering from a recent illness that caused vomiting and diarrhea.

While electrolyte imbalances resulting from vomiting and diarrhea can predispose someone to arrhythmias, they are not as significant a risk factor for atrial flutter as other conditions.

C. The client whose mother and uncle were diagnosed with this same condition.

A family history of atrial flutter may increase the likelihood of developing the condition, but it is not as significant a risk factor compared to other options.

D. The client who had a myocardial infarction and required stent placement.

A history of myocardial infarction and stent placement indicates underlying heart disease, which is a significant risk factor for developing atrial flutter. Cardiac events like myocardial infarction can lead to structural changes in the heart, such as scarring or remodeling, which can predispose individuals to atrial flutter. Therefore, this client is at the highest risk for developing atrial flutter among the options provided.

Full Explanation

A. Stress can contribute to the development of atrial flutter, but it is not the highest risk factor compared to other options.

B. While electrolyte imbalances resulting from vomiting and diarrhea can predispose someone to arrhythmias, they are not as significant a risk factor for atrial flutter as other conditions.

C. A family history of atrial flutter may increase the likelihood of developing the condition, but it is not as significant a risk factor compared to other options.

D. A history of myocardial infarction and stent placement indicates underlying heart disease, which is a significant risk factor for developing atrial flutter. Cardiac events like myocardial infarction can lead to structural changes in the heart, such as scarring or remodeling, which can predispose individuals to atrial flutter. Therefore, this client is at the highest risk for developing atrial flutter among the options provided.

QUESTION

A nurse is developing a plan of care for a client who has Meniere’s disease. Which of the following medications should the nurse anticipate administering?

A. Pantoprazole

Pantoprazole: Pantoprazole is a proton pump inhibitor commonly used to reduce stomach acid production. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions related to excessive stomach acid production. It does not play a role in managing Meniere's disease, which is a disorder of the inner ear characterized by episodes of vertigo, tinnitus, and hearing loss.

B. Warfarin

Warfarin: Warfarin is an anticoagulant medication used to prevent blood clot formation. It is commonly prescribed for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Meniere's disease does not typically require anticoagulant therapy, so warfarin would not be indicated for its treatment.

C. Furosemide

Furosemide: Furosemide is a loop diuretic that helps reduce fluid retention by increasing urine output. In some cases of Meniere's disease, especially those associated with excessive endolymphatic fluid buildup in the inner ear, furosemide may be prescribed to help reduce fluid volume and alleviate symptoms such as vertigo and pressure sensation in the ear.

D. Oxybutynin

Oxybutynin: Oxybutynin is an anticholinergic medication primarily used to treat overactive bladder and urinary incontinence. It works by relaxing smooth muscle in the bladder, reducing bladder spasms and urinary urgency. While some individuals with Meniere's disease may experience associated symptoms such as frequent urination or urinary urgency, oxybutynin is not a standard treatment for Meniere's disease itself.

Full Explanation

Pantoprazole: Pantoprazole is a proton pump inhibitor commonly used to reduce stomach acid production. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions related to excessive stomach acid production. It does not play a role in managing Meniere's disease, which is a disorder of the inner ear characterized by episodes of vertigo, tinnitus, and hearing loss.

B) Warfarin: Warfarin is an anticoagulant medication used to prevent blood clot formation. It is commonly prescribed for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Meniere's disease does not typically require anticoagulant therapy, so warfarin would not be indicated for its treatment.

C) Furosemide: Furosemide is a loop diuretic that helps reduce fluid retention by increasing urine output. In some cases of Meniere's disease, especially those associated with excessive endolymphatic fluid buildup in the inner ear, furosemide may be prescribed to help reduce fluid volume and alleviate symptoms such as vertigo and pressure sensation in the ear.

D) Oxybutynin: Oxybutynin is an anticholinergic medication primarily used to treat overactive bladder and urinary incontinence. It works by relaxing smooth muscle in the bladder, reducing bladder spasms and urinary urgency. While some individuals with Meniere's disease may experience associated symptoms such as frequent urination or urinary urgency, oxybutynin is not a standard treatment for Meniere's disease itself.